Literature DB >> 3054433

Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects.

M Laakso1, M Uusitupa, J Takala, H Majander, T Reijonen, I Penttilä.   

Abstract

We studied the effects of hypocaloric diet (500 kcal/d) and insulin therapy in 15 obese (body mass index greater than 30.0 kg/m2) non-insulin-dependent diabetic patients with secondary drug failure and poor metabolic control. The patients were randomly allocated either to hypocaloric diet (n = 8) or to insulin treatment (n = 7). After 2 weeks of treatment there was a significant improvement in the fasting blood glucose, in the mean diurnal glucose, in glucosuria, and in glucose response to a 75-g oral glucose load in both groups. No change in insulin secretion was seen in either group. Glucose disposal rates (GDR) improved significantly both in the diet-treated group (from 2.34 +/- 0.15 to 4.01 +/- 0.40 mg/kg/min, P less than .01) and in the insulin-treated group (from 2.46 +/- 0.33 to 2.77 +/- 0.29 mg/kg/min, P less than .01). The improvement was greater in the diet-treated group (71%) than in the insulin-treated group (13%, P less than .05). The increase of GDR in the diet-treated group was due to an increase of nonoxidative GDR (from 1.18 +/- 0.17 to 2.98 +/- 0.39 mg/kg/min, P less than .001) as assessed by indirect calorimetry. In the insulin-treated group there was a small increase both in oxidative and nonoxidative GDR, but the changes were not statistically significant. Hepatic glucose output (HGO) in a postabsorptive state decreased significantly both in the diet-treated group (from 2.49 +/- 0.15 to 2.04 +/- 0.10 mg/kg/min, P less than .01) and in the insulin-treated group (from 2.63 +/- 0.23 to 2.05 +/- 0.12 mg/kg/min, P less than .01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3054433     DOI: 10.1016/0026-0495(88)90074-1

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  10 in total

1.  A simple clinical approach to discriminate between "true" and "pseudo" secondary failure to oral hypoglycaemic agents.

Authors:  L Scionti; P Misericordia; A Santucci; F Santeusanio; P Brunetti
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

2.  Common polymorphisms of calpain-10 are associated with abdominal obesity in subjects at high risk of type 2 diabetes.

Authors:  J Pihlajamäki; U Salmenniemi; M Vänttinen; E Ruotsalainen; J Kuusisto; I Vauhkonen; S Kainulainen; M C Y Ng; N J Cox; G I Bell; M Laakso
Journal:  Diabetologia       Date:  2006-05-12       Impact factor: 10.122

3.  Inhibition of obesity-induced hepatic ER stress by early insulin therapy in obese diabetic rats.

Authors:  Weiping Sun; Yan Bi; Hua Liang; Mengyin Cai; Xiang Chen; Yanhua Zhu; Ming Li; Fen Xu; Qiuqiong Yu; Xiaoying He; Jianping Ye; Jianping Weng
Journal:  Endocrine       Date:  2010-11-19       Impact factor: 3.633

4.  Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.

Authors:  I Vauhkonen; L Niskanen; E Vanninen; S Kainulainen; M Uusitupa; M Laakso
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

5.  Effect of protein intake on glycaemic control and renal function in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J Pomerleau; M Verdy; D R Garrel; M H Nadeau
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

6.  Insulin receptor substrate-1 variants in non-insulin-dependent diabetes.

Authors:  M Laakso; M Malkki; P Kekäläinen; J Kuusisto; S S Deeb
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

7.  Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients.

Authors:  I M Jazet; G Schaart; A Gastaldelli; E Ferrannini; M K Hesselink; P Schrauwen; J A Romijn; J A Maassen; H Pijl; D M Ouwens; A E Meinders
Journal:  Diabetologia       Date:  2007-12-14       Impact factor: 10.122

8.  Polymorphisms of the human hexokinase II gene: lack of association with NIDDM and insulin resistance.

Authors:  M Laakso; M Malkki; P Kekäläinen; J Kuusisto; S S Deeb
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

9.  Insulin secretion and its determinants in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals: the Finnish Diabetes Prevention Study.

Authors:  Vanessa D F de Mello; Jaana Lindström; Johan Eriksson; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Jouko Sundvall; Markku Laakso; Jaakko Tuomilehto; Matti Uusitupa
Journal:  Diabetes Care       Date:  2011-12-30       Impact factor: 19.112

10.  Efficacy of Intermittent or Continuous Very Low-Energy Diets in Overweight and Obese Individuals with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analyses.

Authors:  Yi Shan Huang; Qiyan Zheng; Huisheng Yang; Xinwen Fu; Xueqin Zhang; Chenhui Xia; Zebing Zhu; Yu Ning Liu; Wei Jing Liu
Journal:  J Diabetes Res       Date:  2020-01-27       Impact factor: 4.011

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.